IQVIA艾昆纬：2025年炎症性肠病治疗呈上升趋势报告（英文版）

The global burden of illness related to Central Nervous System (CNS) disorders keeps rising unabatedly, with huge economic implications. By 2030, the global economic cost of mental health conditions alone is projected to reach $6 trillion,1 for example, while the economic burden of Alzheimer’s and related dementias is estimated to rise to $4.7 trillion.2 These extraordinary numbers reinforce the urgent need for novel therapeutic interventions to treat CNS disorders, however, the title of our